Do You Need a Different HRT Dose in Perimenopause?

You started hormone therapy expecting the fog to lift, and something did improve, but not enough. Some weeks are fine. Others feel like you are back where you started. If you are still having periods, however erratic, that pattern has a likely explanation, and it is not that hormone therapy does not work for you.

The short answer: yes, perimenopause is often treated differently. Your own hormones are not simply low, they are swinging, sometimes to levels higher than they ever reached in your thirties, before crashing. A dose calibrated for the flat low of postmenopause can be too little to smooth that out, so some women need more estrogen in perimenopause than they will later. The progesterone half usually differs too: cyclically while you are still bleeding, continuously afterwards. And hormone therapy is not contraception, which catches people out.

Why perimenopause is a different problem

The word "menopause" gets used for the whole transition, which hides a genuine physiological difference.

After menopause, ovarian estrogen production has largely stopped and stays stopped. It is a stable, low state. Replacing it is conceptually simple: put back a steady amount.

Perimenopause is not that. Ovulation becomes erratic, and the hormonal response to it becomes exaggerated. Estrogen can spike well above premenopausal levels in some cycles and collapse in others, sometimes within the same month. Progesterone tends to fall earlier and more consistently, because cycles without ovulation produce none at all.

So the experience is one of turbulence rather than absence, which is why the symptoms are often more erratic and, for many women, worse than they are after menopause. It is also why the fix is different. Our perimenopause guide covers the stages in more detail.

The estrogen dose

The principle in perimenopause is to provide enough steady estrogen to flatten the swings, which sometimes means a higher dose than a woman of the same age would need after her final period.

This runs against the instinct many clinicians were trained with, which was to use the lowest dose for the shortest time. That guidance has been substantially revised, and the current approach is to use the dose that controls symptoms, reviewed over time. A woman started on the lowest available patch, told that is the standard, and left there when it is not working is a common and fixable situation.

What it is not is a licence to escalate indefinitely. Dose is titrated against symptoms, with review, by someone who knows what they are doing. If you feel undertreated, the move is to ask for a review, not to double up. We covered what to do when HRT is not working and the dose may be too low separately.

Why blood tests usually will not settle it

It is tempting to want a number. In perimenopause a single estradiol level is close to meaningless, because it captures one point on a curve that may look entirely different next week. Most clinicians treat to symptoms rather than to levels for this reason, and that is mainstream practice rather than a shortcut. There are exceptions, including monitoring absorption in some circumstances and in premature ovarian insufficiency, but for a typical perimenopausal woman the symptom picture is more informative than the blood test. Our guide on HRT without labs explains the reasoning.

The progesterone half is genuinely different

This is the part where perimenopausal and postmenopausal regimens diverge most clearly.

Cyclical while you are still bleeding

If you still have periods, even irregular ones, progesterone is usually given for part of the month rather than every day. That produces a predictable withdrawal bleed, which is the point: it keeps the womb lining shedding on a schedule rather than building up and breaking through unpredictably.

Continuous once you are past it

Once you are a year or so past your last period, most women move to taking progesterone every day, which aims for no bleeding at all. Switching too early is a common cause of frustrating breakthrough bleeding, because the lining is still being stimulated by your own residual ovarian activity.

The timing of that switch is a judgement call, and getting it wrong is a nuisance rather than a danger. Our progesterone page covers the regimens.

The coil option

A hormonal intrauterine device delivers progestogen directly to the womb lining and can serve as the progesterone half of hormone therapy while also providing contraception. For perimenopausal women that dual function is genuinely useful, and it is offered less often than it should be.

Hormone therapy is not contraception

This surprises people and it matters. Standard hormone therapy does not reliably prevent pregnancy. Perimenopausal fertility is low but not zero, and pregnancies do happen in women who assumed the question had closed.

The usual guidance is to continue contraception until a year after your last period if you are over 50, or two years if you are under 50. A hormonal coil handles both jobs at once, which is one more reason it comes up. Our comparison of HRT against the contraceptive pill in perimenopause covers the alternative approach, which is to use the pill itself to manage symptoms while it also provides contraception.

What about testosterone in perimenopause?

It comes up often, and the honest answer is that it is a separate question from estrogen dosing rather than a different dial on the same machine.

Testosterone falls gradually with age rather than dropping at menopause the way estrogen does, so the timing does not map neatly onto the transition. Where it has the strongest evidence is for low sexual desire that is causing distress, after estrogen has been optimised. That sequencing matters: if low desire is being driven by vaginal dryness, exhaustion from broken sleep, or low mood, treating those first often resolves it without testosterone entering the picture at all.

In the United States there is no testosterone product licensed for women, so prescribing is off-label, using a fraction of a male dose. That is legal and mainstream among menopause specialists, but it means many general clinicians will not do it, and most telehealth services do not offer it. Our page on how to get testosterone prescribed as a woman covers the practicalities.

When the symptoms are not hormonal

Worth saying plainly, because the opposite error is also common. Not everything in your forties is perimenopause, and a hormone regimen cannot fix something that is not hormonal.

Thyroid disease, iron deficiency, sleep apnoea, depression and vitamin D deficiency all produce fatigue, low mood and poor concentration, and all are more common in midlife women than people assume. They also coexist happily with perimenopause, so finding one does not rule out the other.

If you have optimised your regimen and a stubborn core of symptoms will not shift, that is a reason to widen the investigation rather than to keep increasing the dose. Our piece on telling thyroid problems from menopause covers the most common of these confusions.

Expect the plan to change

Perimenopause is a moving target, so a regimen that suits you at 47 may not be right at 52. What tends to happen is that estrogen requirements ease somewhat after the transition completes, and the progesterone regimen switches from cyclical to continuous.

This is an argument for staying in contact with a prescriber rather than settling into a repeat prescription and never reviewing it. An annual review is the usual minimum, and sooner if something changes.

What to ask for

• Is my regimen set up for perimenopause specifically, or is it a standard postmenopausal one?
• If symptoms are only partly controlled, is my estrogen dose the reason, and what would a review involve?
• Should my progesterone be cyclical or continuous given where I am in the transition?
• Do I still need contraception, and could a coil cover both?
• When should this be reviewed, and what would prompt a change sooner?

Our questions to ask any HRT provider covers more of this, and the appointment prep tool will build you a written list, which matters when the appointment is fifteen minutes long.

The bottom line

Perimenopause is turbulence, not absence, and treating it as though it were simply early postmenopause is why some women conclude hormone therapy has failed them when the regimen was never right for the stage they are in. If you are still bleeding and only partly better, that is worth raising.

If your current clinician is not confident in this area, our directory lists menopause specialists by state, and telehealth services cover most of the country. For the underlying guidance see The Menopause Society.